Science and Innovation
The US Pharmaceutical Industry during the 1980s
- Publisher's listprice GBP 104.00
-
52 634 Ft (50 128 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 10 527 Ft off)
- Discounted price 42 108 Ft (40 102 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
52 634 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Cambridge University Press
- Date of Publication 9 March 1995
- ISBN 9780521451185
- Binding Hardback
- No. of pages216 pages
- Size 236x158x18 mm
- Weight 466 g
- Language English
- Illustrations 6 b/w illus. 26 tables 0
Categories
Short description:
Examines the relationship between science and innovation in industry, looking particularly at the pharmaceutical industry.
MoreLong description:
This book examines an important phenomenon for competitiveness and innovation in industry: namely the growing use of scientific principles in industrial research. Industrial innovation still arises from systematic trial-and-error experiments with many designs and objects, but these experiments are being guided by a more rational understanding of phenomena. This has important implications for market structure, firm strategies and competition. Science and Innovation focuses on the pharmaceutical industry. It discusses the changes that the notable advances in the life sciences since the 1980s have exerted on the strategies of drug companies, the organization of their internal research, their relationships with scientific institutions, the division of labour between large pharmaceutical firms and small research-intensive suppliers, the productivity of drug discovery and the productivity of R & D.
"Individuals who have not studied the pharmaceutical industry will find this book very readable and informative. Individuals who have had a considerable exposure to the industry will find new insights and interesting topics for further research." Journal of Economic Literature
Table of Contents:
List of figures; List of tables; Preface; List of abbreviations; 1. Introduction; 2. Science and innovation in pharmaceutical research; 3. Economic implications of greater scientific intensity in drug research; 4. In-house scientific research and innovation: case studies of large US pharmaceutical companies; 5. Scientific research and drug discovery: an econometric investigation; 6. A model of the innovation cycle in the pharmaceutical industry; 7. Complementarity and external linkages: the strategies of large firms in biotechnology; 8. Conclusions; Notes; References; Index.
More
